TRIBUNTORAJA.COM, MAKALE - Harga sejumlah kebutuhan pokok di Tana Toraja fluktuatif jelang Iduladha 1446 Hijriah. Pantauan Tribun Toraja di Pasar Sentral Makale, Tana Toraja, Sulawesi Selatan, Selasa ...

Merck’s stock was gaining after the drugmaker beat quarterly earnings expectations again and maintained its full-year outlook despite additional costs related to tariffs. Photo: Getty Images ...

President Donald Trump waves to journalists following his return to the White House on Sunday. (Craig Hudson/For the Washington Post) 1 min President Donald Trump’s administration is focusing on ...

Merck (NYSE:MRK) operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The 52-week range of Merck stock price was $75.93 to $134.63.

Orak-arik hingga setengah matang. Masukkan kwetiau basah dan aduk rata. Tambahkan kecap manis, kecap asin, saus tiram, merica bubuk, serta sedikit garam dan gula. Aduk hingga semua bahan tercampur ...

Lada dan merica adalah rempah populer yang sering digunakan sebagai bumbu masakan. Keduanya berasal dari tanaman Piper Nigrum dalam famili Piperceae. Meski sama-sama dapat menciptakan cita rasa pedas ...

(RTTNews) - Merck KGaA, and SpringWorks Therapeutics, Inc. (SWTX) announced they have entered into a definitive agreement for Merck KGaA to acquire SpringWorks. The purchase price of $47 per share ...

The transaction is expected to close in the second half of 2025. With the deal, Merck KGaA is adding to its rare disease and oncology pipelines. Merck KGaA made good on rumors reported last week, ...

Shares of Merck and Verizon are retreating Friday morning, sending the Dow Jones Industrial Average into negative territory. Supported by world-class markets data from Dow Jones and FactSet ...

Merck KGaA’s protracted pursuit of SpringWorks Therapeutics may be nearing its endgame. The German drugmaker confirmed (PDF) it is in late-stage talks about buying the rare cancer biopharma for ...

Merck & Co. on Thursday warned that tariffs already imposed under the Trump administration are expected to cost the company $200 million in 2025, a figure that does not account for further ...

You can reach Jonathan on Signal at jwosen.27. Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy ...